BAILARD, INC. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$2,367,000
+231.0%
293,000
+225.6%
0.13%
+158.8%
Q1 2020$715,000
-38.1%
90,000
-36.2%
0.05%
-30.1%
Q4 2017$1,156,000
-21.9%
141,0000.0%0.07%
-36.5%
Q3 2017$1,481,000
-4.8%
141,0000.0%0.12%
-8.7%
Q2 2017$1,555,000
+13.9%
141,0000.0%0.13%
+11.5%
Q1 2017$1,365,000141,0000.11%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders